肺动脉高压患者非心胸非产科手术的围术期管理:系统综述与专家共识
该专家共识基于系统文献综述,针对肺动脉高压(PH)患者接受非心胸非产科手术及内镜检查镇静的围术期管理提出推荐。PH患者择期手术30天死亡率为2%-18%,急诊手术升至15-50%,并发症和死亡通常与急性右心室衰竭相关。共识强调个体化术前风险评估与优化、高级围术期计划及多学科协作。
要点
- PH患者择期非心脏手术30天死亡率2%-18%,急诊手术15-50%。
- 死亡风险因素包括PH严重程度标志物及手术、患者相关因素。
- 推荐个体化术前风险评估与优化、多学科围术期规划。
核心结论
- PH患者接受非心胸非产科手术及镇静时并发症和死亡风险显著增加,需系统、循证、多学科方法以最小化并发症。
- 充分的危险分层和个体化围术期计划至关重要。
研究设计与样本
- 系统文献综述,纳入PH患者接受非心脏非产科手术及内镜镇静的研究,以相关临床问题为框架。
主要发现
- 择期非心脏非产科手术30天死亡率为2%-18%,急诊手术为15-50%。
- 并发症和死亡通常与急性右心室衰竭相关。
- 死亡风险因素包括手术相关和患者相关因素,尤其是PH严重程度标志物(如肺血流动力学、运动能力差、右心室功能障碍)。
关键数值与推荐
- 择期非心脏非产科手术30天死亡率2%-18%,急诊手术15-50%。
- 大多数研究强调个体化术前风险评估与优化及高级围术期计划的重要性。
临床怎么用
- 对PH患者进行个体化术前风险评估与优化,制定高级围术期计划。
- 采用系统、循证、多学科方法管理PH患者围术期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH). Sedation also poses a risk to patients with PH. Physiological changes including tachycardia, hypotension, fluid shifts, and an increase in pulmonary vascular resistance (PH crisis) can precipitate acute right ventricular decompensation and death. METHODS: A systematic literature review was performed of studies in patients with PH undergoing non-cardiac and non-obstetric surgery. The management of patients with PH requiring sedation for endoscopy was also reviewed. Using a framework of relevant clinical questions, we review the available evidence guiding operative risk, risk assessment, preoperative optimisation, and perioperative management, and identifying areas for future research. RESULTS: Reported 30 day mortality after non-cardiac and non-obstetric surgery ranges between 2% and 18% in patients with PH undergoing elective procedures, and increases to 15-50% for emergency surgery, with complications and death usually relating to acute right ventricular failure. Risk factors for mortality include procedure-specific and patient-related factors, especially markers of PH severity (e.g. pulmonary haemodynamics, poor exercise performance, and right ventricular dysfunction). Most studies highlight the importance of individualised preoperative risk assessment and optimisation and advanced perioperative planning. CONCLUSIONS: With an increasing number of patients requiring surgery in specialist and non-specialist PH centres, a systematic, evidence-based, multidisciplinary approach is required to minimise complications. Adequate risk stratification and a tailored-individualised perioperative plan is paramount.
引用
- Price LC, Martinez G, Brame A, et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. Br J Anaesth. 2021. PMID: 33612249. doi:10.1016/j.bja.2021.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。